Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Surface Transforms Plc LSE:SCE London Ordinary Share GB0002892528 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.20 -0.89% 22.30 91,089 15:41:32
Bid Price Offer Price High Price Low Price Open Price
21.00 23.60 22.80 22.00 22.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Automobiles & Parts 1.00 -3.03 -1.64 34
Last Trade Time Trade Type Trade Size Trade Price Currency
16:34:20 O 50,000 21.00 GBX

Surface Transforms (SCE) Latest News

More Surface Transforms News
Surface Transforms Takeover Rumours

Surface Transforms (SCE) Discussions and Chat

Surface Transforms (SCE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:34:2121.0050,00010,500.00O
14:41:3222.0010,0002,200.00O
12:21:5422.542,169488.89O
10:03:5121.2015,0003,180.00O
08:53:5021.7713,9203,030.38O
View all Surface Transforms trades in real-time

Surface Transforms (SCE) Top Chat Posts

DateSubject
07/8/2020
09:20
Surface Transforms Daily Update: Surface Transforms Plc is listed in the Automobiles & Parts sector of the London Stock Exchange with ticker SCE. The last closing price for Surface Transforms was 22.50p.
Surface Transforms Plc has a 4 week average price of 22p and a 12 week average price of 14.50p.
The 1 year high share price is 29p while the 1 year low share price is currently 14p.
There are currently 154,598,319 shares in issue and the average daily traded volume is 166,391 shares. The market capitalisation of Surface Transforms Plc is £34,475,425.14.
16/6/2020
14:21
katschmarek: Hi all, I am new on this board, but can see that most (if not all) are really bullish for SCE. Hope this will pay off, as I am also invested. Checking all available news, it's astonishing, that the share price isn't really reflecting these. K.
11/6/2020
20:02
fillspectre: Whilst I am very appreciative of the share price rise. I would still like yet more liquidity and share trades. I can't be pleased. It is a bit galling that the share price dropped to the recent low on equally scant volumes. To my mind quality manufacturing companies with huge barriers to entry and with the very real prospect of rising revenues and increasing markets must be some of the few companies that appeal to investors at present. What else is there? It is very hard to conceive of us not finding ourselves in twelve months time with ST having at least a further two more seriously material contracts under its belt. Fils
11/6/2020
16:43
graham1ty: Nice to see a trade at 22.6p. The highest level.....er, since early March. Does show how quickly the share price fell, and how far. Anyhow, hope the market makers stay short. However, it would take just one Placee to dump 250,000 shares and we would be back below 20p again probably. Let us hope they have all googled the Gemera, and are drooling at the prospect of buying one with their gains on SCE as it roars ahead !!!
10/6/2020
19:25
fillspectre: Pinkfoot2 - bullish about SCE or OCDO? This thread is strictly a SCE affair. Would certainly seem like the share price is consolidating. Volume near 500K. Come on let it repeat tomorrow and Friday! Longshanks - I hope you are not buying again - I was rather hoping the shareholder base was getting more diverse! Aside from the potential material contract announcements we are waiting for - could we get a short term fillip from some quick turnaround track car contracts do you think? Remember the 26th Sept '19 OEM 1 contract announcement for track car discs - £400K - delivered by year end. Fils
27/5/2020
06:07
amt: Logically the share price should be at least 20p. That's where it was before the share issue. That was at the height of the Pandemic when there was a lot of uncertainty around the world. Now it is much clearer that most countries have either recovered or are on the way to recovery the markets are recovering strongly but SCE has got left behind.
15/4/2020
09:54
graham1ty: Fils, yes, I have looked back at some comments and emails. Some are quite interesting. Re Kevin and Michael, it may just be simple affordability. I know nothing about their personal finances, but neither has ever been that well paid. Unlike some blue sky companies, that pay excessively, SCE has not done that. They have plenty of exposure to options. Kevin has 3.5 million options exercisable at 13p and 21p. A share price increase to, say, 30p increases their value by c£500,000. That is enough exposure and incentive to get it right. I am not too worried about 13p. It would obviously have underpinned the price at a higher level if it had been done at 15p. One minor consideration: as the bulk went to major holders, there should be few “flippers̶1;, Placees who just sell for a couple of pence gain. The shares have gone to shareholders who remain deeply committed to the company’s prospects. In this market I would prefer committed, long term holders. So, hopefully, fewer sellers as the price recovers. Now we need to sit back, and wait for the OEMs......
10/2/2020
21:44
pugugly: Thanks Graham and Toffeeman - Thought Omega ran a bell - It did - Appears to be very much a matter of timing - Was sub 10p in August 2019 but was over 17p when first ht screen - With acknowledgement to Rivaldo from my database.But p/e now 18.4 and share price significantly lower at 14.5/15 Back on watchlist for new DD. 14.5//15.5 30/10/15 rivaldo 16 Oct'15 - 10:59 - 3920 of 3939 OT : Richtea, you might also look at ODX. It's only a £15m m/cap and is on a P/E of just 10.6 at 13.88p given 1.3p forecast EPS this year. It also has £2m net cash. It "is one of the UK's leading companies in the fast growing area of food intolerance and also operates in markets supplying tests for allergies and autoimmune diseases and specific infectious diseases through a strong distribution network in over 100 countries, a direct presence in Germany and India, and with a growing network of global partnerships." It has a couple of blue sky products in the share price for free, in particular CD4, an instrument-free, disposable, point-of-care (POC) test for determining CD4+ T-cell counts in HIV-infected patients. This has suffered a number of delays, but could just be on the cusp of resolving the teething development problems. If so, then all bets are off imho. 17/19 29/4/15 FARADAY BUY REC - had totally dropped off my screen tip jumped share price 5%+ Share price: 17p - 19p Market value: £20.7m Faraday risk rating: Hig
19/1/2020
20:25
fillspectre: I can't think I am alone in looking forward to the week ahead w.r.t. a possible further upward share price movement in SCE. Does a new high in the modern era beckon? However an upward price move unprompted by an RNS on thin volumes I have seen before - and I have seen a retreat occur just as rapidly on equally thin volumes. Still I am more optimistic and hopeful than I ever have been that it could be different this time. Perhaps the market has noted that long term shareholders swept in to hoover up sub-24p shares following the recent "anodyne" RNS. A floor seems to have gone in under the price with many posters writing of their frustrations of not buying further shares or being beaten to it. Or perhaps it is a delayed reaction to the PR exercises undertaken by SCE Management in Q4 last year. Fils PS I hesitate to use the adjective "spawny" for such an esteemed share picker and commentator as Rivaldo - but he may well have been just that in buying shares sub-20p following the recent RNS. I raise a glass and toast to Rivaldo hopefully having the honour of purchasing the last ever available sub-20p SCE shares available on the open market!
13/11/2019
21:43
fillspectre: Graham I was going to specifically ask if they, SCE Management, were asked about potential fund raises. They obviously were. Perhaps this is the reason the share price hasn't reacted more - SCE does have a history of fund raises - some of them have been carried out suddenly as well. I share SCE Management's disappointment and frustration but Q1 2020 could be different altogether - patience has thus far been a very necessary characteristic of SCE shareholders. SCE are also doing something with Shares magazine before year end. Fils
09/7/2019
10:21
fillspectre: Well I got my desired 500K + trading volume yesterday. I think it might be a one off this week. Still happy to see SCE share price settle at something over 20p. We are still not two weeks out from the contract announcement RNS. Fils
Surface Transforms share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
SCE
Surface Tr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200807 22:26:01